165 related articles for article (PubMed ID: 30678233)
21. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
[TBL] [Abstract][Full Text] [Related]
22. HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.
Mehta M; Basalingappa K; Griffith JN; Andrade D; Babu A; Amreddy N; Muralidharan R; Gorospe M; Herman T; Ding WQ; Ramesh R; Munshi A
Oncotarget; 2016 Oct; 7(40):64820-64835. PubMed ID: 27588488
[TBL] [Abstract][Full Text] [Related]
23. The Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cells.
Pamarthy S; Jaiswal MK; Kulshreshtha A; Katara GK; Gilman-Sachs A; Beaman KD
Oncotarget; 2015 Oct; 6(33):34206-20. PubMed ID: 26418877
[TBL] [Abstract][Full Text] [Related]
24. Targeted inhibition of Notch1 gene enhances the killing effects of paclitaxel on triple negative breast cancer cells.
Zhou YF; Sun Q; Zhang YJ; Wang GM; He B; Qi T; Zhou Y; Li XW; Li S; He L
Asian Pac J Trop Med; 2017 Feb; 10(2):179-183. PubMed ID: 28237486
[TBL] [Abstract][Full Text] [Related]
25. TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells.
Hernández-Quiles M; Baak R; Orea-Soufi A; Borgman A; den Haan S; Sobrevals Alcaraz P; Jongejan A; van Es R; Velasco G; Vos H; Kalkhoven E
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142452
[TBL] [Abstract][Full Text] [Related]
26. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
27. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27.
Ren YQ; Fu F; Han J
Med Sci Monit; 2015 May; 21():1297-303. PubMed ID: 25943633
[TBL] [Abstract][Full Text] [Related]
28. Notch1 promotes resistance to cisplatin by up-regulating Ecto-5'-nucleotidase (CD73) in triple-negative breast cancer cells.
Qi Y; Li M; Li S; Zeng D; Xiao Y; Li J; Ye Q; Bremer E; Zhang GJ
Cell Death Discov; 2023 Jun; 9(1):204. PubMed ID: 37391408
[TBL] [Abstract][Full Text] [Related]
29. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
30. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
[TBL] [Abstract][Full Text] [Related]
31. TRIB3 inhibits proliferation and promotes osteogenesis in hBMSCs by regulating the ERK1/2 signaling pathway.
Zhang C; Hong FF; Wang CC; Li L; Chen JL; Liu F; Quan RF; Wang JF
Sci Rep; 2017 Sep; 7(1):10342. PubMed ID: 28871113
[TBL] [Abstract][Full Text] [Related]
32. Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of Rarβ.
Paroni G; Zanetti A; Barzago MM; Kurosaki M; Guarrera L; Fratelli M; Troiani M; Ubezio P; Bolis M; Vallerga A; Biancardi F; Terao M; Garattini E
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33081033
[TBL] [Abstract][Full Text] [Related]
33. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
[TBL] [Abstract][Full Text] [Related]
34. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
Phillips TM; McBride WH; Pajonk F
J Natl Cancer Inst; 2006 Dec; 98(24):1777-85. PubMed ID: 17179479
[TBL] [Abstract][Full Text] [Related]
35. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
36. Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer.
Speers C; Zhao SG; Chandler B; Liu M; Wilder-Romans K; Olsen E; Nyati S; Ritter C; Alluri PG; Kothari V; Hayes DF; Lawrence TS; Spratt DE; Wahl DR; Pierce LJ; Feng FY
NPJ Breast Cancer; 2017; 3():29. PubMed ID: 28840192
[TBL] [Abstract][Full Text] [Related]
37. Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer.
Mohammadi-Yeganeh S; Mansouri A; Paryan M
Chem Biol Drug Des; 2015 Nov; 86(5):1185-91. PubMed ID: 25963903
[TBL] [Abstract][Full Text] [Related]
38. Transcriptomic Profiling of MDA-MB-231 Cells Exposed to
Mazzio EA; Lewis CA; Soliman KFA
Cancer Genomics Proteomics; 2017; 14(6):409-425. PubMed ID: 29109091
[TBL] [Abstract][Full Text] [Related]
39. Development and characterisation of acquired radioresistant breast cancer cell lines.
Gray M; Turnbull AK; Ward C; Meehan J; Martínez-Pérez C; Bonello M; Pang LY; Langdon SP; Kunkler IH; Murray A; Argyle D
Radiat Oncol; 2019 Apr; 14(1):64. PubMed ID: 30987655
[TBL] [Abstract][Full Text] [Related]
40. Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients.
Baran B; Sanlav G; Kızmazoğlu D; Kum Özşengezer S; Aktaş S; Altun Z; Olgun N
Clin Med Insights Oncol; 2023; 17():11795549231199926. PubMed ID: 37744426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
